Home Visit
Upload
Cardiolipin ACL-IgM Antibody Serum
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Cardiolipin ACL-IgM Antibody Serum Details in Brief
| Also Known As | Cardiolipin IgM Antibody Test, ACL-IgM Test |
|---|---|
| Purpose | Helps diagnose Antiphospholipid Syndrome (APS), assess thrombosis risk, investigate recurrent miscarriages, and evaluate autoimmune conditions such as lupus |
| Preparation | No special preparation required |
| Fasting | Fasting not required |
| Reporting Time | Same day |
| Cost | 1,050 |
What is a Cardiolipin Antibody (ACL-IgM) Test?
The Cardiolipin Antibody (ACL-IgM) test is a blood test that measures IgM antibodies directed against cardiolipin, a type of fat found in cell membranes. When your immune system mistakenly produces these antibodies, it can lead to abnormal blood clot formation and pregnancy-related complications.
This test helps doctors diagnose Antiphospholipid Syndrome (APS), an autoimmune condition where your body’s immune system attacks its own cells, increasing the risk of clots in veins and arteries. It is also used in the evaluation of autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and unexplained miscarriages.
The test is performed on a blood sample drawn from a vein in your arm and analysed using Fluorescence Immunoassay (FIA) technology.
What Does a Cardiolipin Antibody (ACL-IgM) Test Measure?
The test identifies and quantifies the presence of cardiolipin IgM antibodies in your blood, providing insights into:
- Autoimmune Activity: Detects immune responses against phospholipids in your own cells.
- Clotting Risk Assessment: Evaluates if your blood has a tendency to form abnormal clots.
- Pregnancy Risk Monitoring: Assesses causes of recurrent miscarriages or unexplained infertility.
- Autoimmune Disease Evaluation: Helps diagnose conditions such as Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE).
- Therapy Guidance: Supports treatment planning for patients requiring anticoagulant therapy.
Cardiolipin Antibody (ACL-IgM) Test: Who Needs It and Why It’s Done
What Symptoms May Call for a Cardiolipin Antibody (ACL-IgM) Test?
Your doctor may recommend this test if you experience:
- Unexplained or recurrent blood clots (deep vein thrombosis or pulmonary embolism)
- History of recurrent miscarriages or stillbirths
- Persistent headaches or stroke at a young age
- Low platelet count (thrombocytopenia)
- Symptoms of autoimmune disorders such as lupus (SLE), including joint pain and fatigue
Who Should Get a Cardiolipin Antibody (ACL-IgM) Test?
This test is most useful for:
- Individuals with suspected Antiphospholipid Syndrome (APS)
- Women with recurrent pregnancy losses or unexplained infertility
- Patients with Systemic Lupus Erythematosus (SLE) or other autoimmune diseases
- People with a history of blood clots or stroke without a clear cause
- Individuals undergoing evaluation for autoimmune thrombophilia
Why is a Cardiolipin Antibody (ACL-IgM) Test Done?
The test helps confirm or rule out autoimmune disorders that increase the risk of clotting and pregnancy loss. It is also used to guide treatment decisions, such as starting anticoagulant therapy or monitoring existing autoimmune conditions.
Importance of a Cardiolipin Antibody (ACL-IgM) Test
The Cardiolipin Antibody (ACL-IgM) test provides crucial insight into autoimmune activity that affects blood clotting. Persistent positive results (especially when titres exceed 40 MPL/ml and are repeated 12 weeks apart) are significant indicators of Antiphospholipid Antibody Syndrome (APS).
Detecting this condition early allows doctors to prevent life-threatening complications such as stroke, heart attack, deep vein thrombosis, and pregnancy loss, while also supporting long-term management of autoimmune diseases like lupus.
Cardiolipin Antibody (ACL-IgM) Test Booking & Reports – Metropolis Healthcare
How to Book the Cardiolipin Antibody (ACL-IgM) Test and Get Your Reports?
- Simple Online Booking
Book easily through the Metropolis Healthcare App or website. Select the Cardiolipin Antibody (ACL-IgM) Test, choose your preferred time slot, and provide your address for a home sample collection. You can also visit your nearest Metropolis Lab to give your sample directly. - Safe Home Sample Collection
A trained Metropolis phlebotomist will collect your blood sample from your home while maintaining strict hygiene and safety protocols. - Sample Tracking Updates
You can track your sample status at every step via the Metropolis Healthcare website or app. - Accurate Laboratory Testing
Your sample is analysed at our NABL & CAP accredited laboratories using advanced Fluorescence Immunoassay (FIA) technology for precise results. - Quick & Easy Reports
Receive your test report directly via email, WhatsApp, or download it from the Metropolis Healthcare website or app.
Is Home Sample Collection for Cardiolipin Antibody (ACL-IgM) Test Available Near You?
Yes, Metropolis Healthcare offers convenient home collection for this test. You can schedule a slot that fits your timing and have your sample collected safely at home, saving travel time and ensuring a comfortable testing experience.
How Long Does It Take to Get a Cardiolipin Antibody (ACL-IgM) Test Report?
Reports are usually available the same day after your sample reaches the lab.
Note: Reporting time may vary depending on your location.
Where Can I See or Get Cardiolipin Antibody (ACL-IgM) Test Results?
You can access your reports conveniently through:
- The Metropolis Healthcare website (log in with your credentials)
- The Metropolis Healthcare App
- Email or WhatsApp delivery
- A printed copy available at your nearest Metropolis Lab
Interpreting Cardiolipin Antibody (ACL-IgM) Test Results
What Your Cardiolipin Antibody (ACL-IgM) Test Results May Indicate
|
Result Range (MPL U/mL) |
Interpretation |
|
Negative (<15.0) |
Normal – no significant autoimmune antibody activity detected |
|
Weak Positive (15–40) |
Possible transient autoimmune response or mild antibody elevation |
|
Positive (>40.0) |
Indicates increased risk of thrombosis or pregnancy complications; may suggest Antiphospholipid Syndrome (APS) or Lupus (SLE) |
Understanding Abnormal Cardiolipin Antibody (ACL-IgM) Results by Parameter
|
Parameter |
High Values May Indicate |
Low/Normal Values May Indicate |
|
Cardiolipin Antibody ACL-IgM |
Antiphospholipid Syndrome (APS), autoimmune diseases (e.g., lupus), increased risk of clotting or recurrent miscarriage |
Normal immune activity and low risk of autoimmune clotting disorders |
How Should You Prepare for a Cardiolipin Antibody (ACL-IgM) Test?
The test is simple and requires minimal preparation:
- No fasting required: You may eat and drink normally before your test.
- Medication disclosure: Inform your doctor about all ongoing medicines, particularly anticoagulants or immunosuppressants.
- Biotin awareness: Stop taking high-dose biotin supplements (more than 5 mg per day) at least 8 hours before your test, as it may interfere with results.
- Hydration: Drink water normally to help make blood draw easier.
- Stay relaxed: Avoid extreme stress before your appointment, as it can temporarily affect certain immune responses.
How Is a Cardiolipin Antibody (ACL-IgM) Test Done? (Step-by-Step Procedure)
The Cardiolipin Antibody (ACL-IgM) test is performed using a standard blood collection process:
- Preparation: A tourniquet is tied around your upper arm to make veins more visible.
- Cleaning: The puncture site is cleaned with antiseptic.
- Sample Collection: A sterile needle is used to draw about 3 ml of blood into a gel vacutainer.
- Completion: The needle is removed, and a bandage is applied.
- Processing: The sample is tested using Fluorescence Immunoassay (FIA) to measure cardiolipin IgM antibody levels.
Conditions That May Affect Cardiolipin Antibody (ACL-IgM) Test Accuracy
Certain factors may influence test accuracy:
- Recent infections or inflammation can cause temporary antibody elevation.
- Pregnancy may slightly alter immune system activity and antibody levels.
- Autoimmune flare-ups can cause transient increases in antibody titres.
- High-dose biotin supplementation may interfere with the test; discontinue at least 8 hours before testing.
- Recent vaccination or illness may cause temporary immune system activation affecting results.
Diseases That a Cardiolipin Antibody (ACL-IgM) Test Can Help Detect
This test helps identify or support diagnosis of:
- Antiphospholipid Syndrome (APS)
- Systemic Lupus Erythematosus (SLE)
- Thrombophilia (clotting tendency)
- Recurrent Pregnancy Loss
- Cerebrovascular insufficiency or stroke risk
- Myocardial infarction due to autoimmune clotting
Cardiolipin Antibody (ACL-IgM) Test Price in Different Cities
The cost of a Cardiolipin Antibody (ACL-IgM) Test may vary depending on your location. Here's a table showing the approximate price range for the Cardiolipin Antibody (ACL-IgM) Test at Metropolis Healthcare in major Indian cities:
|
City |
Approximate Cost (INR) |
|
₹ 950 to ₹ 1,100 |
|
|
₹ 950 to ₹ 1,100 |
|
|
₹ 950 to ₹ 1,100 |
|
|
₹ 950 to ₹ 1,100 |
The Cardiolipin Antibody (ACL-IgM) Test cost may vary depending on the city and the specific tests included in the panel. However, Metropolis Healthcare offers competitive Cardiolipin Antibody (ACL-IgM) Test prices across major cities in India.
References
- Petri, M., Orbai, A. M., Alarcón, G. S., et al. (2012). Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism, 64(8), 2677–2686. PMID: 22553077
- Miyakis, S., Lockshin, M. D., Atsumi, T., et al. (2006). International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4(2), 295–306. PMID: 16420554
- Levine, J. S., Branch, D. W., & Rauch, J. (2002). The antiphospholipid syndrome. New England Journal of Medicine, 346(10), 752–763. PMID: 11882732
- Willis, R., & Pierangeli, S. S. (2011). Pathophysiology of the antiphospholipid antibody syndrome. Autoimmunity Reviews, 10(10), 464–468. PMID: 21397621
Cardiolipin ACL-IgM Antibody Serum Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Cardiolipin ACL-IgM Antibody Serum with a clear pricing structure.
The Cardiolipin ACL-IgM Antibody Serum Price in Mumbai is ₹ 1,050 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
High Cardiolipin IgM levels suggest the presence of autoimmune activity, which may increase the risk of blood clots and pregnancy loss, often linked to Antiphospholipid Syndrome (APS) or lupus.
Yes, fasting is not required. You may eat and drink as usual before the test.
Doctors may recommend Beta-2-Glycoprotein IgG Antibody, Lupus Anticoagulant Test, or other autoimmune screening tests for complete evaluation.
A trained professional ties a tourniquet on your arm, cleans the site, and draws about 3 ml of blood into a gel vacutainer for testing.
The risks are minimal. You may feel slight pain or bruising at the puncture site, which usually resolves quickly.
A result below 15 MPL U/mL is considered normal, indicating no significant autoimmune antibody activity.
Yes, temporary infections or inflammatory conditions can cause short-term rises in antibody levels. Persistent positivity confirmed after 12 weeks is considered clinically significant.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp